Redirect Notice
 The previous page is sending you to http://globenewswire.com/news-release/2015/10/08/774562/10151840/en/VBI-Vaccines-Announces-Development-of-a-Novel-Glioblastoma-Immunotherapy-Candidate.html.

 If you do not want to visit that page, you can return to the previous page.